NJ Spotlight News

Business Report: COVID-19 treatments and holiday shopping

Clip: 11/23/2020 | 2m 33s | Video has closed captioning.

Kenilworth-based Merck is hoping a new drug will provide a better treatment option for severely ill COVID-19 patients. Merck is buying the Maryland company OncoImmune for $425 million. Recent late-stage clinical studies found OncoImmune’s medicine reduced the risk of death by 50% for those patients who are hospitalized and on oxygen.

Aired: 11/23/20

Rating: NR

Problems Playing Video? | Closed Captioning

NJ Spotlight News is a local public television program presented by THIRTEEN.